Defect-Assisted Loading and Docking Conformations of Pharmaceuticals in Metal-Organic Frameworks

Angew Chem Int Ed Engl. 2021 Mar 29;60(14):7719-7727. doi: 10.1002/anie.202010231. Epub 2021 Feb 25.

Abstract

Understanding of drug-carrier interactions is essential for the design and application of metal-organic framework (MOF)-based drug-delivery systems, and such drug-carrier interactions can be fundamentally different for MOFs with or without defects. Herein, we reveal that the defects in MOFs play a key role in the loading of many pharmaceuticals with phosphate or phosphonate groups. The host-guest interaction is dominated by the Coulombic attraction between phosphate/phosphonate groups and defect sites, and it strongly enhances the loading capacity. For similar molecules without a phosphate/phosphonate group or for MOFs without defects, the loading capacity is greatly reduced. We employed solid-state NMR spectroscopy and molecular simulations to elucidate the drug-carrier interaction mechanisms. Through a synergistic combination of experimental and theoretical analyses, the docking conformations of pharmaceuticals at the defects were revealed.

Keywords: defects; drug delivery; metal-organic frameworks; molecular simulations; solid-state NMR spectroscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / chemistry*
  • Drug Compounding
  • Drug Liberation
  • Metal-Organic Frameworks / chemistry*
  • Molecular Conformation
  • Molecular Docking Simulation
  • Nanocapsules / chemistry*
  • Organometallic Compounds / chemistry*
  • Organophosphonates / chemistry
  • Phosphates / chemistry
  • Phthalic Acids / chemistry*
  • Porosity
  • Surface Properties

Substances

  • Metal-Organic Frameworks
  • Nanocapsules
  • Organometallic Compounds
  • Organophosphonates
  • Phosphates
  • Phthalic Acids
  • UiO-66
  • Adenosine Monophosphate